Type II minocycline-induced cutaneous and scleral hyperpigmentation

Intern Emerg Med. 2022 Mar;17(2):569-571. doi: 10.1007/s11739-021-02853-2. Epub 2021 Sep 21.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Humans
  • Hyperpigmentation* / chemically induced
  • Minocycline* / adverse effects

Substances

  • Anti-Bacterial Agents
  • Minocycline